AbbVie Other Long-Term Assets 2010-2024 | ABBV

AbbVie other long-term assets for the quarter ending December 31, 2024 were $9.142B, a 0.6% decline year-over-year.

  • AbbVie other long-term assets for 2024 were $9.142B, a 0% decline from 2024.
  • AbbVie other long-term assets for 2024 were $9.142B, a 7.39% increase from 2023.
  • AbbVie other long-term assets for 2023 were $8.513B, a 0% decline from 2023.

AbbVie Other Long-Term Assets 2010-2024 | ABBV

  • AbbVie other long-term assets for 2024 were $9.142B, a 0% decline from 2024.
  • AbbVie other long-term assets for 2024 were $9.142B, a 7.39% increase from 2023.
  • AbbVie other long-term assets for 2023 were $8.513B, a 0% decline from 2023.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B